BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37555661)

  • 1. Cleavage of 14-3-3ε by the enteroviral 3C protease dampens RIG-I-mediated antiviral signaling.
    Andrews DDT; Vlok M; Akbari Bani D; Hay BN; Mohamud Y; Foster LJ; Luo H; Overall CM; Jan E
    J Virol; 2023 Aug; 97(8):e0060423. PubMed ID: 37555661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterovirus D68 3C protease antagonizes type I interferon signaling by cleaving signal transducer and activator of transcription 1.
    Li X; Guo H; Yang J; Liu X; Li H; Yang W; Zhang L; Li Y; Wei W
    J Virol; 2024 Feb; 98(2):e0199423. PubMed ID: 38240591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Chaperone Protein 14-3-3ε in the Regulation of Influenza A Virus-Activated Beta Interferon.
    Tam EH; Liu YC; Woung CH; Liu HM; Wu GH; Wu CC; Kuo RL
    J Virol; 2021 Sep; 95(20):e0023121. PubMed ID: 34379499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.
    Rui Y; Su J; Wang H; Chang J; Wang S; Zheng W; Cai Y; Wei W; Gordy JT; Markham R; Kong W; Zhang W; Yu XF
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.
    Mukherjee A; Morosky SA; Delorme-Axford E; Dybdahl-Sissoko N; Oberste MS; Wang T; Coyne CB
    PLoS Pathog; 2011 Mar; 7(3):e1001311. PubMed ID: 21436888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
    Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
    J Virol; 2021 May; 95(12):. PubMed ID: 33827951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.
    Jagdeo JM; Dufour A; Klein T; Solis N; Kleifeld O; Kizhakkedathu J; Luo H; Overall CM; Jan E
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
    J Virol; 2019 May; 93(10):. PubMed ID: 30867299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
    Qu L; Feng Z; Yamane D; Liang Y; Lanford RE; Li K; Lemon SM
    PLoS Pathog; 2011 Sep; 7(9):e1002169. PubMed ID: 21931545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression.
    Zhu Z; Wang G; Yang F; Cao W; Mao R; Du X; Zhang X; Li C; Li D; Zhang K; Shu H; Liu X; Zheng H
    J Virol; 2016 Dec; 90(24):11106-11121. PubMed ID: 27707918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theilovirus 3C Protease Cleaves the C-Terminal Domain of the Innate Immune RNA Sensor, Melanoma Differentiation-Associated Gene 5, and Impairs Double-Stranded RNA-Mediated IFN Response.
    Miyamoto M; Himeda T; Ishihara K; Okuwa T; Kobayashi D; Nameta M; Karasawa Y; Chunhaphinyokul B; Yoshida Y; Tanaka N; Higuchi M; Komuro A
    J Immunol; 2023 Feb; 210(3):335-347. PubMed ID: 36525065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
    Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity.
    Liu HM; Loo YM; Horner SM; Zornetzer GA; Katze MG; Gale M
    Cell Host Microbe; 2012 May; 11(5):528-37. PubMed ID: 22607805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
    Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
    mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling from the RNA sensor RIG-I is regulated by ufmylation.
    Snider DL; Park M; Murphy KA; Beachboard DC; Horner SM
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2119531119. PubMed ID: 35394863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response.
    Xu C; He X; Zheng Z; Zhang Z; Wei C; Guan K; Hou L; Zhang B; Zhu L; Cao Y; Zhang Y; Cao Y; Ma S; Wang P; Zhang P; Xu Q; Ling Y; Yang X; Zhong H
    J Virol; 2014 Oct; 88(19):11356-68. PubMed ID: 25056901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.